Latest filing published 04 Apr 2022 for ABIOMED INC, €2.3M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David M. Weber is a declared insider of Abiomed Inc (senior executive), with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 3 May 2021 and the latest from 31 March 2022.
The open-market record consists of 2 sales worth €4.4M, with no purchase. The rest of the record consists of 4 share grants and 2 option exercises. In 2022 alone, the filings show no purchases and 2 sales.
On 4 April 2022 came the latest disclosure, an open-market sale for €2.3M in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations